As the medical community converges for the 67th Annual Meeting of the American Society for Radiation Oncology (ASTRO 2025) in San Francisco, a groundbreaking showcase by Fuse Oncology is poised to redefine the landscape of cancer care. Commencing on September 27 or 28, 2025, Fuse Oncology will present its suite
The U.S. Commerce Department, under the Trump administration, has launched a national security review of medical imports—including PPE, consumables, and medical devices—to assess reliance on foreign suppliers for critical health products.
Shares of healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC)
fell 4.3% in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential tariffs.
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session.
The healthcare sector stands on the precipice of a monumental transformation, driven by the relentless advance of Artificial Intelligence (AI). From streamlining administrative tasks to enhancing diagnostic accuracy, AI promises a future of more efficient, accessible, and personalized care. However, this technological revolution is not without its complexities, sparking debates
The Nasdaq 100 (^NDX) is home to some of the biggest success stories in tech and growth investing.
However, certain stocks in the index face challenges like profitability concerns, rising costs, or shifts in market trends.
The healthcare industry is currently experiencing a transformative "golden age," a period marked by an unprecedented surge in scientific breakthroughs and technological advancements. This era is fundamentally altering the landscape of medical treatment and diagnostics, promising a future of more personalized, precise, and preventive medicine. At the forefront of this
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence.
With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.
A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading.
Even if a company is profitable, it doesn’t always mean it’s a great investment.
Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
Shares of healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC)
jumped 2.8% in the afternoon session after the company announced a new distribution agreement for its cardiac imaging agent and received FDA clearance for an innovative CT imaging system.
Generating cash is essential for any business, but not all cash-rich companies are great investments.
Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested that with inflation risks moderating and unemployment remaining low, the Federal Reserve might consider a shift in its monetary policy stance, including potential interest rate cuts. This outlook eased market concerns about prolonged high interest rates and their impact on economic growth. The prospect of lower borrowing costs bolstered investor confidence, particularly in sectors that have lagged, leading to a broad rally across the market.
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner.
Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.
Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 3.5% year on year to $5.01 billion. Its non-GAAP profit of $1.06 per share was 15.5% above analysts’ consensus estimates.
Let’s dig into the relative performance of GE HealthCare (NASDAQ:GEHC) and its peers as we unravel the now-completed Q2 medical devices & supplies - imaging, diagnostics earnings season.
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south.
While some investors embrace risk, mistakes can be costly for those who aren’t prepared.
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns -
over the past six months, healthcare stocks have collectively shed 13.7%. This drawdown is a stark contrast from the S&P 500’s 3.6% gain.
